SEBI Reg. Investment Advisor

Download App
Help Center Subscribe
Money Works 4 Me Logo MoneyWorks4Me
Talk to Advisor
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

Yatharth Hospital & Trauma Care Services Ltd (YATHARTH)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543950 NSE: YATHARTH Hospital & Healthcare Services | Small Cap | Yatharth Hospital Share Price

₹856.60 1.90 (0.22%)

As on 24-Jun'26 16:59

Yatharth Hospital & Trauma Care Services Ltd (YATHARTH)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543950 NSE: YATHARTH Hospital & Healthcare Services | Small Cap | Yatharth Hospital Share Price

₹856.60 1.90 (0.22%)

As on 24-Jun'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹8,254 Cr.
Current Price
₹856.6
52-Week Low / High
₹490 / 890
TTM EPS
₹9.9
TTM Sales
₹592 Cr.
Book Value per Share
₹168.1
P/E Ratio
86.51
Higher than its 5-year historical median
Industry PE
91.4
Price to Book (P/B)
5.10
Higher than its 5-year historical median
Price to Sales (P/S)
13.94
Higher than its 5-year historical median
EV/EBITDA
50.66
Higher than its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
7.42%
Underperforms industry median
Return on Capital Employed (ROCE)
10.42%
Underperforms industry median
Return on Assets (ROA)
7.15%
Operating Profit Margin
28.7%
Net Profit Margin
19.31%
Gross Profit Margin
30.4%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
8.21%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
9.53%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
4.41%
Asset Quality
Promoter Holding
55.80%
Pledged shares (%) of Promoter's holding (%)
10.73%
Reserves
₹1,523 Cr.
Equity
₹96.4 Cr.
Face Value
₹10
All Time Low / High
₹304.00 / 889.80

Yatharth Hospital & Trauma Care Services stock performance

Key Ratios
mw4me loader

Check Before You Invest

Check Before You Invest

Quality

Very Good
Check detailed performance

Valuation

Somewhat Overvalued

Check Valuation charts

Price Trend

Strong
Check Price chart
Q.1 Is Yatharth Hospital & Trauma Care Services Ltd a good quality company?
Yatharth Hospital & Trauma Care Services Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

View More

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

View More
How does Yatharth Hospital & Trauma Care Services Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Yatharth Hospital & Trauma Care Services Ltd vs industry peers?
Yatharth Hospital & Trauma Care Services Ltd revenue CAGR is 27.90%, compared to the industry median CAGR of 1.38%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Yatharth Hospital & Trauma Care Services Ltd?
Promoters hold 55.80% of the Yatharth Hospital & Trauma Care Services Ltd, with 10.73% of their stake pledged, indicating high pledge risk.
Q.1 Stock return of Yatharth Hospital & Trauma Care Services Ltd over the last decade?
Over the last 1 year(s), the stock has delivered a CAGR of 71.5% based on the current price.
View More

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Yatharth Hospital & Trauma Care Services Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation ⓘ

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % ⓘ7.1%9.7%17.9%37.2%37.3%21.1%10.4%-
Value Creation
Index ⓘ		-0.5-0.30.31.81.70.5-0.3-

Growth Parameters ⓘ
Sales ⓘ102133165299372420454592
Sales YoY Gr.-30.3%24.1%81.3%24.4%13%8.2%-
Adj EPS ⓘ0.40.11.96.49.89.89.19.9
YoY Gr.--72.7%1466.7%241.5%52.7%-0.2%-7%-
BVPS (₹) ⓘ8.58.610.617.126.997.5158.3168.1
Adj Net
Profit ⓘ		2.90.812.342.164.28487.795
Cash Flow from Ops. ⓘ1923.525.826.825.61688.7-
Debt/CF from Ops. ⓘ6.34.844.14.40.20-

CAGR ⓘ

9 Years 5 Years 3 Years 1 Years
Sales ⓘNA27.9%15%8.2%
Adj EPS ⓘNA137.7%12.3%-7%
BVPSⓘNA79%110.2%62.4%
Share Price - - - 63%

Key Financial Parameters ⓘ

Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity % ⓘ		5.21.419.646.544.616.67.46.1
Op. Profit
Mgn % ⓘ		19.423.72728.528.628.328.723.4
Net Profit
Mgn % ⓘ		2.90.67.514.117.32019.316.1
Debt to
Equity ⓘ		2.221.510.7000.1
Working Cap
Days ⓘ		0758697128260473137
Cash Conv.
Cycle ⓘ		0925426188118116

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales102133165299372420454
Operating Expenses ⓘ + 82101120214265301324
Manufacturing Costs37505490123148160
Material Costs9131828293745
Employee Cost 18223257576979
Other Costs ⓘ 18171739574640
Operating Profit ⓘ 20314585106119130
Operating Profit Margin (%) 19.4%23.7%27.0%28.5%28.6%28.3%28.7%
Other Income ⓘ + 001121412
Exceptional Items ⓘ 0000000
Interest ⓘ 71413131064
Depreciation ⓘ 8151413131319
Profit Before Tax ⓘ 63186086113119
Tax ⓘ 32518212932
Profit After Tax 311242648488
PAT Margin (%) 2.9%0.6%7.5%14.1%17.3%20.0%19.3%
Adjusted EPS (₹)0.40.11.96.49.89.89.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%

Valuation of Yatharth Hospital - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 5656691121768371,525
Share Capital ⓘ 16161666668696
Reserves ⓘ 394053461117511,429
Debt +12010296858620
Long Term Debt12010292707620
Short Term Debt004151000
Minority Interest0000000
Trade Payables12111316111211
Others Liabilities ⓘ 10323473542839
Total Liabilities ⓘ 1972022112863268781,575

Fixed Assets

Net Fixed Assets ⓘ +146134132122121133161
Gross Block191194209212223248296
Accumulated Depreciation44597690102116134
CWIP ⓘ 000000153
Investments ⓘ 283334474767234
Inventories2332349
Trade Receivables1318327686143171
Cash Equivalents 011213227299
Others Assets ⓘ 712103657304547
Total Assets ⓘ 1972022112863268781,575

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity ⓘ + 19242627261689
PBT ⓘ 83186086113119
Adjustment ⓘ 1128272521610
Changes in Working Capital ⓘ 2-5-18-49-49-67-28
Tax Paid ⓘ -2-2-0-9-32-36-13
Cash Flow From Investing Activity ⓘ + -39-8-4-18-9-167-298
Capex -1-3-3-6-8-34-205
Net Investments -12-5-0-0-0-125-9
Others ⓘ -260-1-130-8-83
Cash Flow From Financing Activity ⓘ + 21-20-23-7-6241347
Net Proceeds from Shares ⓘ 40000577600
Net Proceeds from Borrowing ⓘ 22-1740-1-74-2
Interest Paid ⓘ -5-13-12-12-9-4-1
Dividend Paid ⓘ 0000000
Others ⓘ 011-1444-258-251
Net Cash Flow ⓘ 2-4-111189138

Financial Ratio

PARTICULARSMar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)5.231.4219.6346.4944.5916.587.42
ROCE (%)7.089.7317.9137.1937.3221.0610.42
Asset Turnover Ratio0.520.670.81.21.210.70.37
PAT to CFO Conversion(x)6.33242.170.640.410.191.01
Working Capital Days
Receivable Days45.8042.8055.406679.7099.70126.20
Inventory Days8.106.705.903.102.703.105.30
Payable Days450.50319.80249.80189.50171.50109.7091.10

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.180.000.000.000.0013.8113.8115.3310.7310.73
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Yatharth Hospital & Trauma Care Services Ltd FAQs

The current trading price of Yatharth Hospital on 24-Jun-2026 16:59 is ₹856.6.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 23-Jun-2026 the market cap of Yatharth Hospital stood at ₹8,253.7 Cr

The latest P/E ratio of Yatharth Hospital as of 23-Jun-2026 is 86.51.

The latest P/B ratio of Yatharth Hospital as of 23-Jun-2026 is 5.10.

The 52-week high of Yatharth Hospital is ₹889.8 and the 52-week low is ₹490.4.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Yatharth Hospital is ₹592 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Yatharth Hospital & Trauma Care Services Ltd is a good quality company.

The key valuation ratios of Yatharth Hospital & Trauma Care Services Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Yatharth Hospital & Trauma Care Services Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing

About Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospital & Trauma Care Services is a network of super speciality hospitals across Delhi National Capital Region (NCR) and Madhya Pradesh, capitalising on the robust healthcare infrastructure in these regions to serve a wide patient base in need of tertiary care. The company’s hospitals have been designed to comply with international quality standards with its Noida Extension Hospital accredited by Joint Commission International (JCI), USA and all its hospitals accredited by the National Accreditation Board for Hospitals (NABH). The company’s hospitals have been built on a foundation of talent, trust, technology, service and infrastructure. 

All of its hospitals offer spacious suites along with modern deluxe and super deluxe rooms, and comfortable patient waiting areas. The company’s diagnostic areas are designed with the goals of providing patient-friendly, spacious and relaxing environments. The company has advanced medical equipment such as Azurion catheterization laboratory and are equipped with the latest robotics surgical equipments like the DaVinci, Mako and Cuvis, 1.5 Tesla whole-body MRI with optical digital broadband and embedded express coil technology for minimal patient repositioning and advanced non-contrast MR Angiography, 128 slice CT scan, endo bronchial ultrasound, nerve conduction velocity (NCV), advanced surgical equipment including Thulium Uro laser, flexible scope, advance laparoscope, advance microscopes, Cusa set. These advanced equipments provide for a better and more accurate diagnosis, as well as insight into the surgical procedure, which increases the surgical success rate.

Some of its modular operation theatres are equipped with high efficiency particulate air (HEPA) filters and laminar flow, operating microscopes with image intensifiers. The company’s in-house diagnostic radiology setup and diagnostic labs are well-equipped centres with comprehensive diagnostic capabilities including, haematology, biochemistry, microbiology, molecular biology and histopathology along with 24x7 in-house pharmacy shops.

Business area of the company 

The company is engaged in the business of providing healthcare services, operating hospitals and other allied services, as may be required for the provision of healthcare services. The company has one hospital each in Noida and Greater Noida.

Awards and Accreditations

  • 2020: Recognized as Emerging Hospital Chain in Delhi NCR by Medico Trip India.
  • 2020: Awarded 1stPrize in Swachhta Ranking Competition in the category of Swachh Hospital (for the quarter ended June 2019) in compliance with Swachh Survekshan League 2020 by Noida Authority.
  • 2020: Awarded 1st Rank in Swachhta Ranking Competition in the category of Swachh Hospital (for the quarter ended September 2019) in compliance with Swachh Survekshan League 2020 by Noida Authority.
  • 2021: Certificate of appreciation as ‘Heroes’-Beyond the Call of Duty from Tata Consultancy Services.
  • 2021: Covid Thank You Award by Niva Bupa.
  • 2021: 5 star grading by Infomerics Analysts & Research Private Limited for its hospitals located at Noida, Noida Extension and Greater Noida.
  • 2023: Awarded UP Ratan Samman by Dainik Jagran Inext.
  • 2024-25: Awarded the Best Brand for Excellence in Healthcare at the Economic Times (ET) Edge Best Brands Conclave, in recognition to its consistent innovation and customer-centric approach
  • 2024-25: Noida Extension Hospital accredited by Joint Commission International (JCI) – the first hospital in Uttar Pradesh and seventh in North India to receive this prestigious global accreditation

Milestones

  • 2008: Incorporated the Company and commenced operations
  • 2010: Established first hospital in Greater Noida
  • 2013: Established its second hospital, a 250-bed hospital facility in Noida
  • 2018: Expanded its first hospital, Greater Noida hospital to 400 beds
  • 2019: Commenced operations of its third hospital in, Noida Extension, in May 2019, following the acquisition of its subsidiary AKS in 2016
  • 2022: Acquired its fourth hospital, the Jhansi Orchha hospital, adding 305 beds, through the acquisition of Ramraja Multispeciality Hospital
  • 2023: Listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE)
  • 2024: Acquired its fifth hospital, in Faridabad, Delhi NCR, adding 200 beds
  • 2025: Successfully acquired two hospital, first in Model Town , Delhi and second in Sector 20, Faridabad, Haryana

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: